Mycosis Fungoides in the United States: Increasing Incidence and Descriptive Epidemiology

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 1, 1988, Pages 42-46

  Weinstock, Martin A ^a   Horm, John W ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHNIC OR RACIAL ASPECTS; FUNGUS; HUMAN; MYCOSIS FUNGOIDES; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMAN; MALE; MIDDLE AGE; MYCOSIS FUNGOIDES; NEGROID RACE; PROGNOSIS; REGISTRIES; SEX FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS; SUPPORT, NON-U.S. GOV'T; UNITED STATES;

EID: 0023947178     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410010050033     Document Type: Article

References (32)

1. Young JL, Percy CL, Asire AJ (eds): Surveillance, Epidemiology, and End Results: Incidence and mortality data, 1973-1977. NCI Monogr 1981;57:1-1082.
2. Horm JW, Asire AJ, Young JL, et al.: SEER Program: Cancer Incidence and Mortality in the United States 1973-1981, National Institutes of Health publication 85-1837. Bethesda, Md, National Cancer Institute, 1984.
3. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif, Lifetime Learning Publications, 1982.
4. Weinstock MA, Horm JW: Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides. Cancer, in press.
5. Biggar RJ, Horm J, Fraumeni JF, et al.: Incidence of Kaposi’s sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-1981. JNCI 1984;73:89-94.
6. Wunderman LE: Physician Distribution and Medical Licensure in the US, 1979. Chicago, American Medical Association, 1980.
7. County and City Data Book, 1983. US Bureau of the Census, 1983.
8. State and Metropolitan Area Data Book, 1986. US Bureau of the Census, 1986.
9. Neugut AI: Epidemiology of T-cell leukaemia/ lymphoma. Lancet 1982;2:557-558.
10. Mortality From Malignant Neoplasms: 1955-1965. Geneva, World Health Organization, 1970.
11. Greene MH, Dalager NA, Lamberg SI, et al.: Mycosis fungoides: Epidemiologic observations. Cancer Treat Rep 1979;63:597-606.
12. Cutler SJ, Young JL: Third National Cancer Survey: Incidence data. NCI Monogr 1975;41:1-454.
13. McFadden N, Nyfors A, Tanum G, et al.: Mycosis fungoides in Norway 1960-1980: A retrospective study. Acta Derm Venereol 1983;suppl 109:1-13.
14. Hamminga L, Hermans J, Noordijk EM, et al.: Cutaneous T-cell lymphoma: Clinicopathological relationships, therapy and survival in 92 patients. Br J Dermatol 1982;107:145-156.
15. Slevin NJ, Blair V, Todd IDH: Mycosis fungoides: Response to therapy and survival patterns in 85 cases. Br J Dermatol 1987;116:47-53.
16. Lawrence E (ed): Annual Abstract of Statistics: 1982 Editon. London, Her Majesty’s Stationery Office, 1982, No. 118.
17. Dougan LE, Matthews MLV, Armstrong BK: The effect of diagnostic review on the estimated incidence of lymphatic and hematopoietic neoplasms in Western Australia. Cancer 1981;48:866-872.
18. Edelson RL: Cutaneous T cell lymphoma: Mycosis fungoides, Sezary syndrome, and other variants. J Am Acad Dermatol 1980;2:89-106.
19. Cohen SR, Stenn KS, Braverman IM, et al.: Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980;46:2654-2666.
20. Cyr DP, Geokas MC, Worsley GH: Mycosis fungoides: Hematologic findings and terminal course. Arch Dermatol 1966:94:558-573.
21. Epstein EH, Levin DL, Croft DJ, et al.: Mycosis fungoides: Survival, prognostic features, response to therapy, and autopsy findings. Medicine 1972;15:61-72.
22. Hoppe RT, Cox RS, Fuks Z, et al.: Electron-beam therapy for mycosis fungoides: The Stanford University experience. Cancer Treat Rep 1979;63:691-700.
23. Lamberg SI, Green SB, Byar DP, et al.: Status report of 376 mycosis fungoides patients at four years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep 1979;63:701-707.
24. Vonderheid EC, Van Scott EJ, Wallner PE, et al.: A ten-year experience with topical mechlorethamine for mycosis fungoides: Comparison with patients treated by total-skin electron-beam radiation therapy. Cancer Treat Rep 1979;63:681-689.
25. Poiesz BJ, Ruscetti FW, Gazdar AF, et al.: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
26. Blattner WA, Blayney DW, Robert-Guroff M, et al.: Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis 1983;147:406-416.
27. Wantzin GL, Thomsen K, Nissen NI, et al.: Occurrence of human T cell leukemia virus (type I) antibodies in cutaneous T-cell lymphoma. J Am Acad Dermatol 1986;15:598-602.
28. Blattner WA, Takatsuki K, Gallo RC: Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. JAMA 1983;250:1074-1080.
29. Blayney DW, Blattner WA, Robert-Guroff M, et al.: The human T-cell leukemia-lymphoma virus in the Southeastern United States. JAMA 1983;250:1048-1052.
30. Miller GJ, Pegram SM, Kirkwood BR, et al.: Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer 1986;38:801-808.
31. Fischmann AB, Bunn PA, Guccion JG, et al.: Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sezary syndrome. Cancer Treat Rep 1979;63:591-596.
32. Tuyp E, Burgoyne A, Aitchison T, et al.: A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987;123:196-200.